. 2018 Mar 8;25(1):738–749. doi: 10.1080/10717544.2018.1446476
© 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Figure 1.
Schematic illustration of tumor-targeted therapy of Lys-αTS/CUR NA.